-- 
Novo Gets EU Backing on Levemir for Kids Type 1 Diabetes

-- B y   C h r i s t i a n   W i e n b e r g
-- 
2011-09-23T06:56:07Z

-- http://www.bloomberg.com/news/2011-09-23/novo-gets-eu-backing-on-levemir-for-kids-type-1-diabetes.html
Novo Nordisk A/S  said  the European
Committee for Medicinal Products for Human Use (CHMP) has
adopted a positive opinion on the extended use of Novo Nordiskâ€™s
basal insulin analogue, insulin detemir, in children aged two to
five years with type 1 diabetes.  To contact the editor responsible for this story:
Christian Wienberg at 
 cwienberg@bloomberg.net  